Your browser doesn't support javascript.
loading
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
Tam, Constantine S; Brown, Jennifer R; Kahl, Brad S; Ghia, Paolo; Giannopoulos, Krzysztof; Jurczak, Wojciech; Simkovic, Martin; Shadman, Mazyar; Österborg, Anders; Laurenti, Luca; Walker, Patricia; Opat, Stephen; Chan, Henry; Ciepluch, Hanna; Greil, Richard; Tani, Monica; Trnený, Marek; Brander, Danielle M; Flinn, Ian W; Grosicki, Sebastian; Verner, Emma; Tedeschi, Alessandra; Li, Jianyong; Tian, Tian; Zhou, Lei; Marimpietri, Carol; Paik, Jason C; Cohen, Aileen; Huang, Jane; Robak, Tadeusz; Hillmen, Peter.
Affiliation
  • Tam CS; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; University of Melbourne, Parkville, VIC, Australia; St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia; Royal Melbourne Hospital, Parkville, VIC, Australia. Electronic address: constantine.tam@alfred.org.au.
  • Brown JR; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kahl BS; Washington University School of Medicine, St Louis, MO, USA.
  • Ghia P; Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
  • Giannopoulos K; Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland; Hematology Department, St John's Cancer Centre, Lublin, Poland.
  • Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.
  • Simkovic M; Fourth Department of Internal Medicine-Haematology, University Hospital, Hradec Kralove, Czech Republic; Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Shadman M; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Österborg A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Laurenti L; Fondazione Policlinico Universitario A Gemelli UCSC, Rome, Italy.
  • Walker P; Peninsula Private Hospital, Frankston, VIC, Australia.
  • Opat S; Monash Health, Clayton, VIC, Australia; Monash University, Clayton, VIC, Australia.
  • Chan H; North Shore Hospital, Auckland, New Zealand.
  • Ciepluch H; Copernicus Regional Oncology Center, Gdansk, Poland.
  • Greil R; Third Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria.
  • Tani M; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy.
  • Trnený M; First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic.
  • Brander DM; Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
  • Flinn IW; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
  • Grosicki S; Department of Hematology and Cancer Prevention, Health Sciences Faculty, Medical University of Silesia, Katowice, Poland.
  • Verner E; Concord Repatriation General Hospital, Concord, NSW, Australia; University of Sydney, Sydney, NSW, Australia.
  • Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Li J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Tian T; BeiGene USA, San Mateo, CA, USA.
  • Zhou L; BeiGene, Beijing, China.
  • Marimpietri C; BeiGene USA, San Mateo, CA, USA.
  • Paik JC; BeiGene USA, San Mateo, CA, USA.
  • Cohen A; BeiGene USA, San Mateo, CA, USA.
  • Huang J; BeiGene USA, San Mateo, CA, USA.
  • Robak T; Medical University of Lodz, Lodz, Poland.
  • Hillmen P; St James's University Hospital, Leeds, UK.
Lancet Oncol ; 23(8): 1031-1043, 2022 08.
Article in En | MEDLINE | ID: mdl-35810754

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Sequoia / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Sequoia / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article